BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11807191)

  • 1. Prognosis for fertility and ovarian function after treatment with radioiodine for thyroid cancer.
    Vini L; Hyer S; Al-Saadi A; Pratt B; Harmer C
    Postgrad Med J; 2002 Feb; 78(916):92-3. PubMed ID: 11807191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testicular dose and fertility in men following I(131) therapy for thyroid cancer.
    Hyer S; Vini L; O'Connell M; Pratt B; Harmer C
    Clin Endocrinol (Oxf); 2002 Jun; 56(6):755-8. PubMed ID: 12072044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose radioiodine treatment for differentiated thyroid carcinoma is not associated with change in female fertility or any genetic risk to the offspring.
    Bal C; Kumar A; Tripathi M; Chandrashekar N; Phom H; Murali NR; Chandra P; Pant GS
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):449-55. PubMed ID: 16095849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy outcome after diagnosis of differentiated thyroid carcinoma: no deleterious effect after radioactive iodine treatment.
    Chow SM; Yau S; Lee SH; Leung WM; Law SC
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):992-1000. PubMed ID: 15234032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative radioiodine therapy in the treatment of differentiated thyroid cancer.
    Maxon HR
    Q J Nucl Med; 1999 Dec; 43(4):313-23. PubMed ID: 10731782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma.
    Menzel C; Grünwald F; Schomburg A; Palmedo H; Bender H; Späth G; Biersack HJ
    J Nucl Med; 1996 Sep; 37(9):1496-503. PubMed ID: 8790201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of scanning doses of iodine-131 on subsequent first ablative treatment outcome in patients operated on for differentiated thyroid carcinoma.
    Muratet JP; Daver A; Minier JF; Larra F
    J Nucl Med; 1998 Sep; 39(9):1546-50. PubMed ID: 9744340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic administration of 131I for differentiated thyroid cancer: radiation dose to ovaries and outcome of pregnancies.
    Garsi JP; Schlumberger M; Rubino C; Ricard M; Labbé M; Ceccarelli C; Schvartz C; Henri-Amar M; Bardet S; de Vathaire F
    J Nucl Med; 2008 May; 49(5):845-52. PubMed ID: 18413399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation Dose-rate Reduction Pattern in Well-differentiated Thyroid Cancer Treated with I-131.
    Khan SA; Khan MS; Arif M; Durr-e-Sabih ; Rahim MK; Ahmad I
    J Coll Physicians Surg Pak; 2015 Jul; 25(7):510-3. PubMed ID: 26208555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testicular function after radioiodine therapy for thyroid carcinoma.
    Wichers M; Benz E; Palmedo H; Biersack HJ; Grünwald F; Klingmüller D
    Eur J Nucl Med; 2000 May; 27(5):503-7. PubMed ID: 10853804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer.
    Samuel AM; Rajashekharrao B; Shah DH
    J Nucl Med; 1998 Sep; 39(9):1531-6. PubMed ID: 9744337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiated thyroid carcinoma: Incremental diagnostic value of
    Zilioli V; Peli A; Panarotto MB; Magri G; Alkraisheh A; Wiefels C; Rodella C; Giubbini R
    Endocrine; 2017 Jun; 56(3):551-559. PubMed ID: 27709475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian function after radioiodine therapy in patients with thyroid cancer.
    Souza Rosário PW; Alvarenga Fagundes T; Villas-Boas Fagundes AS; Barroso AL; Lamego Rezende L; Lanza Padrão E; Guimarães VC; Horta AC; Franco M; Purisch S
    Exp Clin Endocrinol Diabetes; 2005 Jun; 113(6):331-3. PubMed ID: 15977100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
    Jarzab B; Handkiewicz-Junak D; Wloch J
    Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of second primary malignancy in differentiated thyroid carcinoma treated with radioactive iodine therapy.
    Lang BH; Wong IO; Wong KP; Cowling BJ; Wan KY
    Surgery; 2012 Jun; 151(6):844-50. PubMed ID: 22341041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome after radioiodine therapy in 107 patients with differentiated thyroid carcinoma and initial bone metastases: side-effects and influence of age.
    Petrich T; Widjaja A; Musholt TJ; Hofmann M; Brunkhorst T; Ehrenheim C; Oetting G; Knapp WH
    Eur J Nucl Med; 2001 Feb; 28(2):203-8. PubMed ID: 11303891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malformations in the offspring of women with thyroid cancer treated with radioiodine for the ablation of thyroid remnants.
    do Rosário PW; Barroso AL; Rezende LL; Padrão EL; Borges MA; Purisch S
    Arq Bras Endocrinol Metabol; 2006 Oct; 50(5):930-3. PubMed ID: 17160219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Radioactive Iodine Therapy on Ovarian Function and Fertility in Female Thyroid Cancer Patients: A Systematic Review and Meta-Analysis.
    Piek MW; Postma EL; van Leeuwaarde R; de Boer JP; Bos AME; Lok C; Stokkel M; Filipe MD; van der Ploeg IMC
    Thyroid; 2021 Apr; 31(4):658-668. PubMed ID: 33012254
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroglobulin flare response after radioiodine ablation in 2 patients with differentiated thyroid cancer.
    Tsang JF; Levin DP; Leslie WD
    Clin Nucl Med; 2015 May; 40(5):421-2. PubMed ID: 25546193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.